title: Generalized eruptive histiocytosis: a possible therapeutic cure?
authors.forename: Y-J
authors.initials: YJ
authors.lastname: Deng
authors.forename: F
authors.initials: F
authors.lastname: Hao
authors.forename: C-L
authors.initials: CL
authors.lastname: Zhou
authors.forename: R-S
authors.initials: RS
authors.lastname: Sun
authors.forename: M-M
authors.initials: MM
authors.lastname: Xiang
authors.forename: J-W
authors.initials: JW
authors.lastname: Wang
authors.forename: B-Y
authors.initials: BY
authors.lastname: Zhong
authors.forename: Q-Y
authors.initials: QY
authors.lastname: Ye
authors.forename: R-Q
authors.initials: RQ
authors.lastname: Liu
mesh_terms: D000328:Adult; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005148:Facial Dermatoses / Q000188:drug therapy*; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use
chemical_list: D003879:Dermatologic Agents; D006886:Hydroxychloroquine; D013792:Thalidomide; D011241:Prednisone